NEW YORK (Reuters Health) – An implantable cardioverter-defibrillator (ICD) should be considered when patients with long QT syndrome (LQTS) have syncope while on beta-blockers. That’s according to authors…
NEW YORK (Reuters Health) – Daclizumab added to ongoing interferon-beta treatment further decreases multiple sclerosis disease activity, according to a multicenter phase II trial reported online February 16…
Gary Small, MD, Director, UCLA Center on Aging, UCLA, discusses brain health and the impact that lifestyle factors have over genetics on brain health, and in particular, diet,…
Arya Nick Shamie, MD, Associate Professor of Orthopedic Surgery and Neurosurgery, UCLA David Geffen School of Medicine, discusses minimally invasive spine surgery, which is becoming safer and less…
David Heber, MD, Professor of Medicine, Director, UCLA Center for Human Nutrition, discusses nutrition in breast cancer, and the role of diabetes and obesity in post-menopausal breast cancer,…
Joshua Grill, PhD, Director, Katherine and Benjamin Kagan Alzheimer’s Disease Treatment Development Program, UCLA, Alzheimer’s Disease, which is currently a worldwide healthcare crisis and it is expected to…
Joseph Demer, MD, Professor of Opthalmology and Neurology, UCLA David Geffen School of Medicine, discusses lateral rectus ligament dysfunction in the eye, its diagnosis and management techniques used…
Joseph Demer, MD, Professor of Opthalmology and Neurology, UCLA David Geffen School of Medicine, discusses eye muscles, which are regulated by connective tissue structures called pulleys, and horizontal…
Ian A Cook, MD, Director of Unipolar Depression Research, UCLA David Geffen School of Medicine, discusses new treatment options for depression, particularly deep brain stimulation and injectable treatment…
Andrew Charles, MD, Professor, Director of Headache Research and Treatment Program, UCLA David Geffen School of Medicine, discusses migraine diagnosis and diagnostic criteria that focus on associated symptoms…
